Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950103-25-009643
Filing Date
2025-07-31
Accepted
2025-07-31 17:14:09
Documents
16
Effectiveness Date
2025-07-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dp231894_s8.htm S-8 42316
2 EXHIBIT 5.1 dp231894_ex0501.htm EX-5.1 12958
3 EXHIBIT 23.1 dp231894_ex2301.htm EX-23.1 2036
4 EXHIBIT 99.1 dp231894_ex9901.htm EX-99.1 72921
5 EX-FILING FEES dp231894_exfilingfees.htm   iXBRL EX-FILING FEES 13309
6 GRAPHIC image_001.jpg GRAPHIC 3900
  Complete submission text file 0000950103-25-009643.txt   268322

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT dp231894_exfilingfees_htm.xml XML 4549
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)